NHS logo

Neuberger High Yield Strategies Fund Inc. (NHS) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

NHS, $ (piyasa değeri 0) fiyatla Financial Services işi olan Neuberger High Yield Strategies Fund Inc.'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 47/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 16 Mar 2026
47/100 AI Puanı

Neuberger High Yield Strategies Fund Inc. (NHS) Finansal Hizmetler Profili

CEOJoseph Vincent Amato
MerkezNew York City, US
Halka Arz Yılı2003

Neuberger High Yield Strategies Fund Inc. (NHS) is a US-based closed-end fund focusing on global high-yield debt, managed by Neuberger Berman. With a high dividend yield of 15.60% and investments across sectors like auto parts, healthcare, and telecom, NHS offers income-seeking investors exposure to fixed-income markets.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

Neuberger High Yield Strategies Fund Inc. presents a compelling investment case for income-seeking investors, driven by its high dividend yield of 15.60% and a focus on high-yield debt securities. The fund's attractive profit margin of 75.7% suggests efficient management and strong income generation from its investments. Key catalysts include the ongoing demand for high-yield investments in a low-interest-rate environment and the fund's ability to capitalize on undervalued debt opportunities. However, potential risks include increased credit risk associated with high-yield debt during economic downturns and fluctuations in interest rates that could impact the fund's net asset value. The fund's beta of 0.75 indicates lower volatility compared to the broader market, which may appeal to risk-averse investors. Continued monitoring of the fund's performance, asset allocation, and macroeconomic conditions is crucial for assessing its long-term investment potential.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • High Dividend Yield: NHS boasts a dividend yield of 15.60%, making it a noteworthy option for income-focused investors.
  • Strong Profit Margin: The fund exhibits a high profit margin of 75.7%, indicating efficient management and profitable investment strategies.
  • Low Beta: With a beta of 0.75, NHS demonstrates lower volatility compared to the overall market, potentially offering a more stable investment.
  • Global Diversification: NHS invests in fixed income markets across the globe, providing diversification benefits and exposure to various economies.
  • Experienced Management: Managed by Neuberger Berman Investment Advisers LLC, the fund benefits from the expertise and resources of a well-established asset management firm.

Rakipler & Benzerleri

Güçlü Yönler

  • High dividend yield.
  • Strong profit margin.
  • Experienced management team.
  • Global diversification.

Zayıflıklar

  • Exposure to high-yield debt risk.
  • Sensitivity to interest rate changes.
  • Potential for credit losses.
  • Closed-end fund structure can lead to trading at a discount to NAV.

Katalizörler

  • Ongoing: Continued demand for high-yield investments in a low-interest-rate environment.
  • Ongoing: Fund's ability to capitalize on undervalued debt opportunities.
  • Upcoming: Potential for increased dividend payouts due to strong earnings.
  • Upcoming: Strategic partnerships with institutional investors (within 1-2 years).
  • Upcoming: Launch of new high-yield products (within 18-24 months).

Riskler

  • Potential: Increased credit risk associated with high-yield debt during economic downturns.
  • Potential: Fluctuations in interest rates that could impact the fund's net asset value.
  • Ongoing: Competition from other asset management firms.
  • Potential: Regulatory changes that could impact the fund's operations.
  • Ongoing: Market volatility and uncertainty.

Büyüme Fırsatları

  • Expansion into Emerging Markets: NHS can explore growth opportunities by increasing its exposure to high-yield debt in emerging markets. These markets often offer higher yields compared to developed markets, but also come with increased risks. By carefully selecting investments in emerging markets, NHS can potentially enhance its returns and diversify its portfolio. The emerging market debt market is projected to grow to $3 trillion by 2028, presenting a significant opportunity for NHS to expand its asset base.
  • Focus on Sustainable Investing: NHS can attract socially responsible investors by incorporating environmental, social, and governance (ESG) factors into its investment process. By focusing on companies with strong ESG profiles, NHS can align its investments with the growing demand for sustainable investing. The ESG investing market is expected to reach $50 trillion by 2025, indicating a substantial opportunity for NHS to tap into this growing trend.
  • Leveraging Technology for Enhanced Analysis: NHS can leverage advanced technologies such as artificial intelligence and machine learning to improve its credit analysis and risk management capabilities. By using AI-powered tools, NHS can identify undervalued debt securities and better assess the creditworthiness of potential investments. This can lead to improved investment performance and reduced risk. The adoption of AI in asset management is projected to increase significantly over the next few years, providing NHS with a competitive advantage.
  • Strategic Partnerships with Institutional Investors: NHS can forge strategic partnerships with institutional investors such as pension funds and endowments to secure long-term capital commitments. By partnering with these investors, NHS can enhance its stability and reduce its reliance on retail investors. Institutional investors are increasingly allocating capital to alternative investment strategies, including high-yield debt, presenting an opportunity for NHS to attract significant investments. These partnerships could materialize within the next 1-2 years.
  • Development of New High-Yield Products: NHS can develop new high-yield products tailored to specific investor needs and preferences. This could include creating specialized funds focused on particular sectors or geographies. By offering a wider range of products, NHS can attract a broader investor base and increase its assets under management. The demand for specialized high-yield products is growing as investors seek more targeted investment solutions. New product offerings could be launched within the next 18-24 months.

Fırsatlar

  • Expansion into emerging markets.
  • Focus on sustainable investing.
  • Leveraging technology for enhanced analysis.
  • Strategic partnerships with institutional investors.

Tehditler

  • Economic downturns.
  • Increased competition.
  • Regulatory changes.
  • Rising interest rates.

Rekabet Avantajları

  • Established brand and reputation of Neuberger Berman.
  • Experienced management team with expertise in high-yield investing.
  • Access to proprietary research and analysis.
  • Diversified portfolio reduces risk.

NHS Hakkında

Neuberger High Yield Strategies Fund Inc., established on July 28, 2003, is a closed-end fixed income mutual fund managed by Neuberger Berman Investment Advisers LLC, a subsidiary of Neuberger Berman LLC. The fund's primary objective is to generate current income by investing in fixed income markets worldwide. NHS focuses on high yield debt securities, commonly known as junk bonds, issued by companies across diverse sectors. These sectors include auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. The fund's investment strategy involves identifying and capitalizing on opportunities in the global high-yield debt market. By investing in a diversified portfolio of high-yield securities, NHS aims to mitigate risk while maximizing income potential for its investors. The fund's management team employs a rigorous research process to evaluate creditworthiness and assess the relative value of potential investments. Neuberger Berman Investment Advisers LLC leverages its expertise and resources to actively manage the fund's portfolio, adjusting allocations based on market conditions and investment opportunities. This active management approach allows NHS to adapt to changing market dynamics and seek to deliver consistent returns to its shareholders. The fund is domiciled in the United States and trades on the New York Stock Exchange.

Ne Yaparlar

  • Invests in global fixed income markets.
  • Focuses on high yield debt securities.
  • Manages a diversified portfolio of bonds.
  • Seeks to generate current income for investors.
  • Employs active management strategies.
  • Conducts credit analysis to assess risk.

İş Modeli

  • Generates income through interest payments from bond holdings.
  • Earns management fees based on assets under management (AUM).
  • Utilizes leverage to enhance returns.
  • Actively trades securities to optimize portfolio performance.

Sektör Bağlamı

Neuberger High Yield Strategies Fund Inc. operates within the asset management industry, which is characterized by intense competition and evolving market dynamics. The industry is influenced by factors such as interest rates, economic growth, and investor sentiment. Funds like NHS compete with other closed-end funds, ETFs, and mutual funds for investor capital. The high-yield debt market, in particular, is sensitive to credit spreads and default rates. As investors search for yield in a low-interest-rate environment, high-yield strategies can attract significant inflows, but they also carry higher risks compared to investment-grade bonds. The fund's performance is closely tied to the overall health of the global economy and the creditworthiness of the companies in which it invests.

Kilit Müşteriler

  • Retail investors seeking income.
  • Institutional investors looking for high-yield exposure.
  • Wealth management clients.
  • Retirement savers.
AI Güveni: 81% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

Neuberger High Yield Strategies Fund Inc. (NHS) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

NHS için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

NHS için Wall Street fiyat hedefi analizi.

MoonshotScore

47/100

Bu puan ne anlama geliyor?

MoonshotScore, NHS'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Joseph Vincent Amato

President and Chief Investment Officer - Equities

Joseph V. Amato serves as the President and Chief Investment Officer of Equities at Neuberger Berman. He is a member of the firm’s Investment Oversight Committee. Amato joined Neuberger Berman in 1993 and has held various leadership positions within the company. His extensive experience in the financial industry spans several decades, providing him with deep insights into market dynamics and investment strategies. He is known for his expertise in equity investments and his ability to navigate complex market conditions.

Sicil: During his tenure at Neuberger Berman, Joseph Amato has overseen significant growth and innovation in the firm's equity division. He has been instrumental in developing and implementing investment strategies that have delivered strong returns for clients. His leadership has contributed to Neuberger Berman's reputation as a leading asset management firm. He has successfully guided the firm through various market cycles, demonstrating his ability to adapt to changing conditions and deliver consistent results.

Neuberger High Yield Strategies Fund Inc. Hissesi: Cevaplanan Temel Sorular

NHS için değerlendirilmesi gereken temel faktörler nelerdir?

Neuberger High Yield Strategies Fund Inc. (NHS) şu anda yapay zeka skoru 47/100, düşük puanı gösteriyor. Temel güçlü yan: High dividend yield.. İzlenmesi gereken birincil risk: Potential: Increased credit risk associated with high-yield debt during economic downturns.. Bu bir finansal tavsiye değildir.

NHS MoonshotScore'u nedir?

NHS şu anda MoonshotScore'da 47/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

NHS verileri ne sıklıkla güncellenir?

NHS fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler NHS hakkında ne diyor?

NHS için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

NHS'a yatırım yapmanın riskleri nelerdir?

NHS için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Increased credit risk associated with high-yield debt during economic downturns.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

NHS'ın P/E oranı nedir?

NHS için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için NHS'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

NHS aşırı değerli mi, yoksa düşük değerli mi?

Neuberger High Yield Strategies Fund Inc. (NHS)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

NHS'ın temettü verimi nedir?

Neuberger High Yield Strategies Fund Inc. (NHS) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • AI analysis pending, limiting comprehensive insights.
  • Financial data based on available information as of 2026-03-16.
Veri Kaynakları

Popüler Hisseler